Onconephrology: Core Curriculum 2023

被引：14

作者：

Yarandi, Niloufarsadat ^{[1
]}

Shirali, Anushree C. ^{[1
]}

机构：

[1] Yale Univ, Sch Med, Sect Nephrol, POB 208029, New Haven, CT 06520 USA

来源：

AMERICAN JOURNAL OF KIDNEY DISEASES | 2023年 / 82卷 / 06期

关键词：

AKI; cancer; CKD; hypertension; onconephrology; proteinuria;

D O I：

10.1053/j.ajkd.2023.04.014

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Onconephrology focuses on management of kidney disease in cancer, which manifests itself in a proteinuria, and electrolyte disorders. Many of these syndromes result from cancer treatments including chemotherapy, immunotherapy, chimeric antigen receptor T cells, and stem cell transplant. Others are due to kidney-specific effects of the cancer, as seen with monoclonal gammopathy or glomerular diseases associated with malignancy. Further, cancer risk itself is heightened in patients erations. In this installment of AJKD's Core Curriculum in Nephrology, we review these and other core concepts in onconephrology, using a case-based approach to highlight clinical decision making.

引用

页码：743 / 761

页数：19